Marie Cullberg

3PUBLICATIONS
9CO-AUTHORS
Molecular targetsPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jul 08, 2025
Population Pharmacokinetics and Exposure-Response Analyses for Capivasertib in Combination With Fulvestrant in Patients With Breast Cancer.

Carlos Fernandez Teruel, Marie Cullberg, Ignacio González-García

|Aug 10, 2024
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours.

Carlos Fernandez-Teruel, Marie Cullberg, Cath Eberlein

|Jul 26, 2021
Concentration-QT modelling shows no evidence of clinically significant QT interval prolongation with capivasertib at expected therapeutic concentrations.

Veronika Voronova, Marie Cullberg, Philip Delff

Pageof 1

Frequent Collaborators

2 joint publications

Carlos Fernandez-Teruel

2 joint publications

Diansong Zhou

1 joint publications

Veronika Voronova

1 joint publications

Joanna Parkinson

1 joint publications

Cath Eberlein

1 joint publications

Simon T Barry

1 joint publications

Ignacio González-García

1 joint publications

Gaia Schiavon

1 joint publications

Ling Zhang

Frequent Collaborators

2 joint publications

Carlos Fernandez-Teruel

2 joint publications

Diansong Zhou

1 joint publications

Veronika Voronova

1 joint publications

Joanna Parkinson

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 06, 2015

8.8K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.7K
High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
10:01

High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening

Published on : Mar 31, 2022

3.4K
See more related videos

Top Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 06, 2015

8.8K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.7K
High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
10:01

High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening

Published on : Mar 31, 2022

3.4K
See more related videos